Endometrial Cancer Clinical Trial
Official title:
Randomized Phase III Trial in MMR Deficient Endometrial Cancer Patients Comparing Chemotherapy Alone Versus Dostarlimab in First Line Advanced/Metastatic Setting
Phase 3, randomized, multicentre study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial cancer.
Phase III, randomized, open label, multi-centre study. Randomization on a 1:1 ratio, stratification performed according to: - Prior adjuvant chemotherapy (yes or no) - Prior pelvic radiotherapy (yes or no). ;
| NCT number | NCT05201547 |
| Study type | Interventional |
| Source | ARCAGY/ GINECO GROUP |
| Contact | Aurélie MORVAN |
| Phone | 01 84 85 20 29 |
| [email protected] | |
| Status | Not yet recruiting |
| Phase | Phase 3 |
| Start date | February 2022 |
| Completion date | May 2029 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04586335 -
Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
|
Phase 1 | |
| Completed |
NCT03820024 -
MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
|
N/A | |
| Active, not recruiting |
NCT00587886 -
Estrogen, Diet, Genetics and Endometrial Cancer
|
||
| Recruiting |
NCT05124743 -
HLA Typing and Tumor Neoantigen Identification for a Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
|
||
| Recruiting |
NCT03876860 -
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
|
N/A | |
| Recruiting |
NCT04569773 -
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
|
||
| Active, not recruiting |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
| Not yet recruiting |
NCT04995731 -
Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer
|
||
| Terminated |
NCT02907073 -
Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02413606 -
ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?
|
N/A | |
| Completed |
NCT02549989 -
Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
|
Phase 2 | |
| Completed |
NCT02058550 -
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy
|
Phase 1 | |
| Completed |
NCT01979003 -
Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
|
Early Phase 1 | |
| Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
| Completed |
NCT02351479 -
Hula, a Physical Activity Intervention for Female-Cancer Survivors
|
N/A | |
| Completed |
NCT01922778 -
Screening for Endometrial Abnormalities in Overweight and Obese Women
|
N/A | |
| Recruiting |
NCT01679522 -
Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer
|
N/A | |
| Completed |
NCT02068820 -
Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
|
N/A |